Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Lee430on Jan 29, 2021 3:57pm
96 Views
Post# 32422867

RE:RE:Paul must be fuming -

RE:RE:Paul must be fuming -So if all goes well with our trials who will be negotiating the future deals or partnerships for us?

ANALIAS00 wrote: He has a lot of experience. I am sure he knows everything that can impact SP. If not we dont have the right CEO. But he can still take action to sweep clean. Some are saying there was no better deal on the table. That is the point. TH can only blame themself for their strategy or their absence of strategy. They should be working better to sell their story. Many people here said that already and it is an obvious conclusion to this situation. And they also should explain why they had to pull down their pants so early and so quickly after the good news. Is it because that deal was already concluded 2 months back ? Again I dont see any other reason. They certainly did not received and concluded that deal in few days after the PR.
palinc2000 wrote: I dont think he saw the tsunami coming ,,,
He is a top notch CEO with great competence in all aspects of an operating  and R&D company except financing and he learned the hard way,,,,I am interested and anxious to see how he will react....New broom sweeps clean !!!!




<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse